MedPath

Sandoz Pharmaceuticals AG

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Topotecan Hydrochloride for Injection

Product Name
和美新
Approval Number
国药准字HJ20181105
Approval Date
Jan 12, 2023
NMPA

Topotecan Hydrochloride for Injection

Product Name
和美新
Approval Number
国药准字HJ20181104
Approval Date
Jan 12, 2023
NMPA

Zoledronic Acid Injection

Product Name
密固达
Approval Number
国药准字HJ20181132
Approval Date
Sep 27, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.